肿瘤细胞治疗研究
ALL SOURCES
Pluripotent stem cell-derived chimeric antigen receptor-natural killer cells targeting epidermal growth factor receptor 2 for cancer immunotherapy.
嵌合抗原受体自然杀伤（CAR-NK）细胞正成为同种异体细胞免疫治疗的一个有前景的平台。
Ten years of translational innovation in HER2-targeted immune cell therapy - A comprehensive review of the work of the University of Debrecen Cell and
这些努力共同凸显了工程化免疫细胞克服传统疗法关键局限的潜力，并支持 CAR 类方法在实体瘤中的持续演进。
Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
背景/目的：针对HER2阳性肿瘤的单克隆抗体治疗常出现耐药，需要替代治疗策略。
CAR-NK cell therapy for overcoming antigen heterogeneity and immunosuppressive tumor microenvironments.
嵌合抗原受体工程化NK 细胞（CAR-NK）已成为癌症免疫治疗中的一种变革性策略，具有不依赖MHC的细胞毒性、降低移植物抗宿主病风险以及同种异体“现货型”适用性。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
